Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma

Area of Science:

• Oncology
• Molecular Biology
• Cancer Metabolism

Background:

• Tumor-specific metabolic alterations support cancer cell growth and survival.
• Metabolic heterogeneity in cancers complicates the development of targeted therapies.
• Medulloblastoma (MB) is a highly heterogeneous pediatric brain tumor with distinct molecular subgroups.

Purpose of the Study:

• To review metabolic rewiring mechanisms in medulloblastoma (MB).
• To highlight how MB cells utilize metabolic networks for growth, survival, invasion, metastasis, and therapy resistance.
• To discuss potential therapeutic strategies targeting MB metabolism.

Main Methods:

• Literature review focusing on recent advances in MB genomics, single-cell sequencing, and tumor models.
• Analysis of metabolic pathways and energy production networks in MB.
• Discussion of existing drugs targeting cellular metabolism.

Main Results:

• MB cells exhibit complex metabolic adaptations to support rapid proliferation and survival.
• Intratumoral cellular diversity contributes to metabolic heterogeneity in MB.
• Targeting metabolic vulnerabilities offers potential for novel therapeutic interventions.

Conclusions:

• Understanding MB metabolic rewiring is crucial for developing effective treatments.
• Targeting energy metabolism may enhance current MB therapies and overcome resistance.
• Further research into MB metabolic pathways can identify new therapeutic targets.